Prognostic Significance of 99mTc Hynic-rh-Annexin V Scintigraphy During Platinum-Based Chemotherapy in Advanced Lung Cancer
- 20 June 2007
- journal article
- lung cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (18) , 2534-2539
- https://doi.org/10.1200/jco.2006.10.1337
Abstract
Purpose: The purpose of this study was to evaluate if sequential 99mTc Hynic-rh- annexin V scintigraphy (TAS) can predict outcome in patients with advanced lung cancer, shortly after the start of platinum-based chemotherapy. Patients and Methods: In 16 consecutive chemotherapy-naive patients with advanced stage non–small-cell lung cancer scheduled for platinum-based chemotherapy, TAS was performed before and within 48 hours after the start of therapy. Chemotherapy-induced changes in tumor annexin V uptake, calculated as maximum count per pixel and expressed as percentage to baseline value, were compared with treatment response determined according to Response Evaluation Criteria in Solid Tumors. Results: A significant correlation (r2 = 0.86; P = .0001) was found between annexin V metabolic changes and treatment outcome. All patients with notably increased annexin V tumor uptake showed complete or partial response. Less prominently increased or decreased uptake correlated with stable or progressive disease. Conclusion: TAS is a promising test to predict tumor response in patients with advanced lung cancer early in the course of platinum-based chemotherapy.Keywords
This publication has 23 references indexed in Scilit:
- Changes in the natural history of nonsmall cell lung cancer (NSCLC)—Comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990Cancer, 2006
- Phase I/IIa Study of Cisplatin and Gemcitabine As Induction Chemotherapy Followed by Concurrent Chemoradiotherapy With Gemcitabine and Paclitaxel for Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)Oncology Reports, 2004
- Apoptosis defects and chemotherapy resistance: molecular interaction maps and networksOncogene, 2004
- In Vivo Imaging of Chemotherapy‐Induced Apoptosis in Human CancersAnnals of the New York Academy of Sciences, 2003
- Current status of the molecular mechanisms of anticancer drug-induced apoptosisCancer Chemotherapy and Pharmacology, 2002
- Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial ct scan-based studyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Is Cisplatin-Induced Cell Death Always Produced by Apoptosis?Molecular Pharmacology, 2001
- In vivo detection and imaging of phosphatidylserine expression during programmed cell deathProceedings of the National Academy of Sciences, 1998
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988